Meeting Handout
Speaker Presentations
How to build an early lung cancer detection program
Vickie J. Beckler, MBA, RN
Why IPN Programs are Needed Now More Than Ever
Debra S Dyer MD FACR
The importance of using ctDNA to detect minimal residual disease (MRD)
Natasha Leighl MD MMSc FRCPC FASCO
Lung Cancer Screening: is there a role for Artificial Intelligence?
William R. Mayfield MD FACS
Lung Cancer Early Detection: How do we help more people?
Amy C. Moore, PHD
Incidental Pulmonary Nodule (IPN) and Low‐Dose CT Lung Cancer Screening Programs: How They Compare
Ray U. Osarogiagbon, MBBS FACP
Methylation, Circulating Tumor Cells And Exosomes, Other Efforts For Early Lung Cancer Detection
Luis E. Raez MD FACP FCCP
Community Advocacy for Lung Screening Programs: The commitment of advocacy, the power of partnerships
Maureen Rigney, LICSW
Cancer Interception And Clonal Hematopoiesis
Christian Rolfo, MD, PhD, MBA, Dr.hc
How to Complement Biomarker Testing with Diagnostic Imaging
Catherine R. Sears, M.D., ATSF
Challenges of Tissue Acquisition & Biomarker Testing in The Community and Academic Settings
Gerard A. Silvestri MD, MS
Lung Cancer Screening In Never Smokers & High Risk Populations
Janakiraman Subramanian MD, MPH
Current Management of the Incidental Nodule in Chest CT and the Need for Artificial Intelligence
David F. Yankelevitz, MD
